The Pennant Group (NasdaqGS:PNTG) Q4 2025 Earnings call February 26, 2026 12:00 PM ET Company ParticipantsBrent Guerisoli - CEOBrian Tanquilut - Equity Research analystJohn Gochnour - President and COOKirk Cheney - EVP, General Counsel and Corporate SecretaryLynette Walbom - CFOConference Call ParticipantsBen Hendrix - VP and Senior Equity AnalystDavid MacDonald - Managing Director and Senior Equity Research AnalystJared Haase - VP and Senior Equity AnalystRaj Kumar - Senior Research Associate and AnalystSt ...

The Pennant Group (NasdaqGS:PNTG) Q4 2025 Earnings call February 26, 2026 12:00 PM ET Company ParticipantsBrent Guerisoli - CEOBrian Tanquilut - Equity Research analystJohn Gochnour - President and COOKirk Cheney - EVP, General Counsel and Corporate SecretaryLynette Walbom - CFOConference Call ParticipantsBen Hendrix - VP and Senior Equity AnalystDavid MacDonald - Managing Director and Senior Equity Research AnalystJared Haase - VP and Senior Equity AnalystRaj Kumar - Senior Research Associate and AnalystSt ...

Financial Data and Key Metrics Changes - The company reported full-year consolidated revenue of $947.7 million, an increase of $252.5 million, or 36.3% year-over-year [6] - Adjusted EBITDA for the full year was $72.5 million, up $19.2 million, or 36% compared to the previous year [6] - Adjusted earnings per share for the full year reached $1.18, exceeding the midpoint of the updated annual guidance of $1.16 [5][6] Business Line Data and Key Metrics Changes - In the home health and hospice segment, Q4 revenue was $233.3 million, an increase of $91.3 million, or 64.3% year-over-year, with adjusted EBITDA of $33.7 million, up $12.4 million, or 58.2% [12] - Fourth quarter admissions surged 81.3%, with Medicare admissions growing 87.5% year-over-year [12] - The senior living segment saw full-year revenue improve to $215 million, an increase of $39.2 million, or 22.3% over the prior year [16] Market Data and Key Metrics Changes - The average daily census in hospice care grew to 5,060, a 46.9% increase over the prior year quarter [15] - Same-store Medicare admissions in home health grew 8.2%, with a 3.7% increase in Medicare revenue per episode [13] - All store occupancy in senior living rose 200 basis points to 80.6%, with same-store occupancy ending the year at 82.1% [17] Company Strategy and Development Direction - The company is focused on optimizing performance and driving operational excellence while remaining open to selective acquisitions [9] - Key focus areas include leadership development, clinical excellence, employee experience, margin improvement, and growth [8] - The company aims to continue the upward trajectory of its senior living business, with significant growth potential ahead [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying trajectory of the business despite reimbursement headwinds [15] - The company anticipates a full-year revenue guidance of $1.13 billion to $1.17 billion for 2026, reflecting a 22.4% increase at the midpoint [11] - Management highlighted the importance of local leadership in responding to community needs and driving organic growth [57] Other Important Information - The company completed significant acquisitions, including the purchase of over 50 locations from UnitedHealth and Amedisys, enhancing its reach in the Southeast [8] - The balance sheet remains strong, with a net debt to adjusted EBITDA ratio of 1.7 times, well under the covenant limit [23] - The company generated $21 million of cash flows from operations in Q4, bringing the year-to-date total to $48.3 million [23] Q&A Session Summary Question: Is the guidance conservative due to the integration of Amedisys and UnitedHealth? - Management confirmed that the guidance reflects a conservative approach due to expected initial noise during the transition of operations [30] Question: How do joint ventures perform compared to non-JV agencies? - Management stated that joint ventures are treated like any Pennant business, focusing on local leadership and collaboration with health system partners to achieve exceptional outcomes [32] Question: How does the Amedisys and UnitedHealth asset ramp-up compare to Signature? - Management noted similarities in leadership quality and operational strengths, expressing confidence in the transition process based on past experiences [39] Question: What is the expected same-store revenue growth for 2026? - Management indicated a projected 7% increase in home health and hospice revenue for 2026, despite anticipated rate decreases [51] Question: What is the competitive landscape in the hospice segment? - Management highlighted a normalization in growth rates post-pandemic, with strong organic growth driven by local community needs [78]

The Pennant Group, Inc. (PNTG) reported $289.32 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 53.2%. EPS of $0.34 for the same period compares to $0.24 a year ago.The reported revenue represents a surprise of +5.97% over the Zacks Consensus Estimate of $273.04 million. With the consensus EPS estimate being $0.31, the EPS surprise was +8.52%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectat ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________________________________________________________________________ FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. (State or Other Jurisdiction of (I.R.S. Employer Incorporation or Organization) Identification No.) Delaware 83-3349931 1675 East Riverside Drive, Suite 150, Eagle, ID 83616 For the fiscal year ended December 31, ...

Pennant Reports Fourth Quarter and Fiscal Year 2025 Results Exhibit 99.1 Conference Call and Webcast scheduled for tomorrow, February 26, 2026 at 10:00 am MT EAGLE, Idaho – February 25, 2026 (GLOBE NEWSWIRE) - The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.84 for the full year and $0.24 for the fourth quarter of 2025. Pennant ...

Core Insights - The Pennant Group, Inc. reported strong financial results for the year 2025, with significant increases in revenue, net income, and adjusted earnings per share, indicating robust growth in its home health, hospice, and senior living services [1][2][4]. Financial Performance - Total revenue for 2025 was $947.7 million, a 36.3% increase from the previous year, with fourth-quarter revenue reaching $289.3 million, up 53.2% year-over-year [2][22]. - Net income for the full year was $29.6 million, a 31.1% increase, while fourth-quarter net income was $8.6 million, up 50.0% compared to the prior year quarter [2][3]. - Adjusted net income for 2025 was $41.6 million, reflecting a 38.9% increase, with fourth-quarter adjusted net income at $12.2 million, up 43.1% year-over-year [2][32]. Segment Performance - Home Health and Hospice Services segment revenue for 2025 was $732.7 million, a 41.0% increase, with fourth-quarter revenue at $233.3 million, up 64.3% [2][22]. - Senior Living Services segment revenue for 2025 was $215.0 million, a 22.3% increase, with fourth-quarter revenue at $56.1 million, up 19.6% [2][27]. Operational Metrics - Total home health admissions for 2025 were 86,076, a 44.1% increase, with fourth-quarter admissions at 28,941, up 81.3% [2][24]. - Hospice average daily census for 2025 was 4,204, a 28.6% increase, with fourth-quarter census at 5,060, up 46.9% [2][27]. - Senior living average occupancy for the fourth quarter was 80.6%, an increase of 200 basis points year-over-year, with average monthly revenue per occupied room at $5,238, up 5.6% [2][27]. Guidance for 2026 - The company anticipates total revenue for 2026 to be between $1,133.6 million and $1,171.8 million, with adjusted earnings per diluted share expected to be between $1.26 and $1.36 [5][6]. - Adjusted EBITDA for 2026 is projected to be between $88.5 million and $94.1 million [5][6]. Management Commentary - The CEO highlighted 2025 as a year of record-breaking performance and strategic growth, emphasizing the importance of operational excellence and successful integration of new operations [4][6]. - The COO noted the focus on maintaining momentum and delivering strong results across all key growth metrics, indicating confidence in continued success in 2026 [4][6].

Core Viewpoint - The Pennant Group, Inc. is set to release its fourth quarter and fiscal year 2025 financial results on February 25, 2026, followed by a live webcast on February 26, 2026, where management will discuss these results [1][2]. Group 1: Financial Results Announcement - The Pennant Group, Inc. will issue its financial results for the fourth quarter and fiscal year 2025 on February 25, 2026 [1]. - A live webcast is scheduled for February 26, 2026, at 10:00 a.m. Mountain Time to discuss the financial results [2]. Group 2: Company Overview - The Pennant Group, Inc. operates as a holding company for independent subsidiaries providing healthcare services, including home health, hospice, and senior living in 17 states [4]. - Each subsidiary operates independently with its own management, employees, and assets, indicating a decentralized operational structure [4].

Group 1 - The Wasatch Micro-Cap Fund reported a return of 9.52% in Q3 2025, underperforming the benchmark Russell Microcap® Growth Index, which returned 19.93% [1] - The Pennant Group, Inc. (NASDAQ:PNTG) is highlighted as a key stock, with a one-month return of 13.43% and a 52-week gain of 7.66% [2] - The Pennant Group, Inc. reported revenue of $229 million in Q3 2025, reflecting an increase of $48.4 million or 26.8% from Q3 2024 [4] Group 2 - The Pennant Group operates a network of senior-living facilities and home-health agencies, focusing on purchasing underutilized assets to drive patient volumes [3] - Concerns regarding proposed Medicare reimbursement rates negatively impacted sentiment for The Pennant Group's stock, although expectations for a more favorable final rate structure could support recovery [3] - The number of hedge funds holding The Pennant Group increased from 27 to 30 in Q3 2025, indicating growing interest [4]

Core Viewpoint - The Pennant Group, Inc. (PNTG) is showing potential for a bullish breakout due to a recent "golden cross" in its moving averages, indicating a favorable technical setup for investors [1]. Technical Analysis - PNTG's 50-day simple moving average has crossed above its 200-day simple moving average, forming a "golden cross," which is a bullish signal for traders [1]. - A successful golden cross event consists of three stages: a price decline bottoming out, the shorter moving average crossing above the longer moving average, and the stock maintaining upward momentum [2]. Performance Metrics - Over the past four weeks, PNTG has experienced a gain of 14.4%, indicating positive price movement [3]. - The company currently holds a 2 (Buy) rating on the Zacks Rank, suggesting it may be positioned for further breakout [3]. Earnings Outlook - PNTG has seen 2 upward revisions in earnings estimates over the past 60 days, with no downward revisions, contributing to a positive earnings outlook for the current quarter [3]. - The Zacks Consensus Estimate for PNTG has also increased, reinforcing the bullish sentiment around the stock [3][5].